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Abstract.11
Background: Anosognosia is common in patients with Alzheimer’s disease (AD) and it is frequently related to an increase
in time of care demand.
12
13
Objective: The aim of the study was to examine the effect of anosognosia on the total costs of informal care in patients with
AD.
14
15
Methods: This was a prospective longitudinal study with community-dwelling AD patients. Anosognosia, time of informal
care, and the use of support services (e.g., day care centers) were recorded at baseline and after 24 months. The cost of
informal caregiving was calculated as ‘market price’.
16
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Results: At baseline, the prevalence of anosognosia was 54.3% (n = 221), and 43.9% were classified as mild-AD. The average
time of care was 5 h/day ± 2.4 (IADL: 1.3 h/day ± 1.4 and BADL: 3.6 h/day ± 1.5). Thirty percent of the patients used home
care services, and 25.1% attended a day care center. Patients with anosognosia received more time of care and were more likely
to use support services than did their no-anosognosia peers, including institutionalization. The mean cost of support services
was 490.4D /month (SD = 413.1D ; range = 25–2,212.38D ), while the overall cost of care (support services plus informal care)
was 1,787D /month (SD = 972.4D ), ranging from 834.1D in mild-AD without anosognosia patients, to 2,424.8D in severe-AD
with incident anosognosia patients.
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Conclusions: Anosognosia was associated with an increased number of hours of informal care, and a greater use of support
services, regardless of the severity of the dementia, which lead to an increase of the total family-care costs.
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INTRODUCTION29
The costs of dementia care are frequently divided30
into formal and informal costs. Informal costs refer31
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to the amount of unpaid informal caregiver’s time 32
spent on patient’s care [1] and represents 40 to 80% 33
of dementia costs, which range from US$315 billion 34
to US$604 billion in western countries [2–5]. 35
The cost of informal care is mainly determined 36
by the place of residence of the patient. As much as 37
83% of the people with dementia want to stay in their 38
own home, as published by the annual report ‘Sup- 39
port, Stay, Save’ of the Alzheimer’s Society (UK) [6].
ISSN 1387-2877/16/$35.00 © 2016 – IOS Press and the authors. All rights reserved
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Most patients with dementia are cared for at home,40
which causes an increase in informal costs, adding an41
economic burden on families instead of on healthcare42
systems [1].43
Caring for a relative with dementia has a hard44
impact on the emotional, physical, and economical45
situation. The economic value of this impact has been46
estimated using the cost of professional caregivers as47
a basis (cost of formal care) or by providing a mone-48
tary value to the possible loss of opportunities due to49
the time spent as a caregiver [7, 8].50
Previous studies related informal costs to the pro-51
gressive increase of the patient’s dependency, to the52
severity of the dementia, and to the presence of53
behavioral and psychological symptoms of demen-54
tia (BPSD) [5, 9]. One of the BPSD that has been55
reported to increase the perceived caregiver’s burden56
is anosognosia, the lack of disease awareness [10, 11].57
The prevalence of anosognosia in AD patients is58
over 25%, and it is cognitive decline-related, with59
around 80% of the patients with severe AD having60
anosognosia [12]. Patients with anosognosia present61
more BPSD than patients with no anosognosia, such62
as delusions [13], disinhibition, and apathy [14].63
BPSD cause an increase of the burden, the distress,64
and the cost of care [15]. Besides, the quality of65
life perception and the efficiency of neurocognitive66
rehabilitation are negatively affected by the presence67
of anosognosia [16–17]. All these factors associ-68
ated with the presence of anosognosia, even when69
they may also appear in patients with mild cogni-70
tive impairment [18], have an effect on the impact71
of the informal care required by the patient. Further-72
more, patients with anosognosia are more likely to73
engage in risky behaviors, which increases the bur-74
den of the caregivers due to the need of increased75
supervision and control, which may even lead to early76
institutionalization [19]. Moreover, the presence of77
anosognosia has been linked to an increased sense78
of isolation, greater physical and emotional burden,79
and a patient-caregiver relationship characterized by80
greater dependency [20]. Overall, therefore, the pres-81
ence of anosognosia may be associated with greater82
care needs, either regarding the number of hours of83
care needed or the use of health and social support84
services.85
To our knowledge, this is the first study to ana-86
lyze the impact of anosognosia on informal costs.87
Our hypothesis was that the presence of anosognosia88
may cause an increase in the cost of care due to the89
increased time of care, the increased use of resources,90
or to both.
METHODS 91
Design and study population 92
This was a longitudinal study involving a 24-month 93
follow-up of a consecutive sample of outpatients seen 94
at the Dementia Unit (Department of Neurology) of 95
Bellvitge University Hospital (Hospitalet de Llobre- 96
gat, Barcelona). They were all diagnosed as either AD 97
according to the criteria of the Diagnostic and Statis- 98
tical Manual of Mental Disorders [21] r probable 99
AD according to the criteria of the National Institute 100
of Neurological and Communicative Disorders and 101
Stroke / Alzheimer’s disease and Related Disorders 102
Associations (NINCDS-ADRDA) [22]. The main 103
caregiver was defined as the person with ongoing 104
responsibility for helping the patient with activities 105
of daily living (ADL). All the caregivers were rela- 106
tives of the patient, mainly daughters/sons or spouses. 107
Informed consent was obtained for all participants. 108
Patients were excluded if they presented with vascular 109
or traumatic events, alcohol or substance dependency 110
or abuse, and if they had severe communication prob- 111
lems or had a severity of Global Deterioration Scale 112
(GDS) stage 7 [23] that prevented them from respond- 113
ing adequately to the assessment questions. The study 114
was approved by the hospital’s Clinical Research 115
Ethics Committee (ref. PR162/10). 116
Data collection 117
A structured questionnaire designed ad hoc was 118
used to gather information on the use of resources 119
such as day care centers, home care services, resi- 120
dential care, and memory-training programs, as well 121
as on the time spent helping with both instrumental 122
ADL (IADL) and basic ADL (BADL). The question- 123
naire also allowed collecting sociodemographic data 124
of both patients and caregivers. 125
The time of care was assessed using two items of 126
the Resources Utilization in Dementia scale (RUD) 127
[24], which were administered to the caregivers: “On 128
a typical care day during the last 30 days, how 129
much time per day did you assist the patient with 130
tasks such as toilet visits, eating, dressing, grooming, 131
walking and bathing?” as BADL, and “On a typi- 132
cal care day during the last 30 days, how much time 133
per day did you assist the patient with tasks such 134
as shopping, food preparation, housekeeping, laun- 135
dry, transportation, taking medication and managing 136
ﬁnancial matters?” as a question of IADL. 137
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The cognitive assessment of the patients was based138
on the Mini-Mental State Exam (MMSE), a brief cog-139
nitive assessment tool with a score ranging from 0140
to 30 (the lower the score the greater the cognitive141
deterioration) [25].142
The functional assessment of the patient was based143
on the Disability Assessment for Dementia (DAD)144
[26]. The DAD provides a measure of basic and145
instrumental ADL and was administered to the main146
caregiver. It comprises 40 items and its total score147
ranges from 40 to 80 (the higher the score the greater148
the patient’s functional ability).149
The severity of dementia was classified according150
to the criteria of the GDS, a tool designed to determine151
the stage of a patient’s dementia. GDS 4 corresponds152
to mild dementia, GDS 5 to moderate dementia, and153
GDS 6 to moderately severe dementia.154
The presence of BPSD was evaluated by means155
of the Neuropsychiatric Inventory (NPI) [27], which156
comprises 12 subscales that assess the frequency and157
severity of 12 neuropsychiatric symptoms (or BPSD),158
based on information provided by caregivers. The159
score ranges from 0 to 144, and the higher the score160
the greater the frequency and severity of neuropsy-161
chiatric symptoms.162
Finally, anosognosia was assessed using the163
Anosognosia Questionnaire-Dementia (AQ-D) [28],164
a tool that is administered both to the patient and165
the caregiver. It comprises 30 items assessing cogni-166
tive/functional deficits and changes in the patient’s167
behavior, with each item being rated according to168
the frequency of occurrence, from 0 (never) to 3169
(always). The total score ranges from 0 to 90. The170
degree of anosognosia is estimated on the basis of171
the difference between the patient and caregiver’s172
scores. The cut-off for the presence of anosognosia173
was established at difference ≥32 points. We iden-174
tified asymptomatic cases when anosognosia was175
not present in any evaluation, incident cases when176
patients without anosognosia at baseline developed177
it during the follow up, and persistent cases when178
anosognosia was present both at baseline and during179
the follow up.180
Procedure181
Neurologists from the Dementia Unit selected eli-182
gible patients according to the inclusion criteria. The183
sample was recruited between January and December184
2011 and the study finished on March 2014. The aims185
of the study were explained to all the participants in186
an introductory interview, and an informed consent187
Table 1
Monthly cost of the health and social support services considered
in the study
Service Mean D /month
Memory-Training programs 25.00∗
Day center∗∗
Weekly 336.72
Daily 617.72
Home care services†
Occasionally 77.53
Weekly 232.60
Daily 387.70
Residential care∗∗ 1,595.06
∗approximate cost for 10 h/month; ∗∗Data from the Catalan
government for such services in 2010; †Price/hour established
by Barcelona City Council for home care services in 2013;
Occasionally = 1 day/week; Weekly = 3–4 days/week; Daily = 5–7
days/week.
was obtained from both patients and caregivers before 188
proceeding. The patients and their caregivers were 189
then interviewed separately by two clinical psychol- 190
ogists trained in the administration of the study 191
protocol instruments. 192
The economical cost of time of care was evaluated 193
as market price, thus attributing the cost per hour of 194
private professionals [29]. The attribution of costs and 195
the cost of using different health and social resources 196
are shown in Table 1. The cost of day care centers 197
and residential care was derived from the costs estab- 198
lished by the Catalan government [30], the cost per 199
hour for home care services was based on the figures 200
set by the Barcelona City Council [31], and the cost 201
of attending memory-training programs and day care 202
centers was taken as the mean cost of 10 hours/month 203
of such services in the area where the patient lived. 204
The hourly cost of informal care was taken to be 205
equivalent to the cost per hour of a geriatric nursing 206
assistant providing help with BADL. The standard for 207
costs per hour was obtained from the Catalan Office 208
of National Statistics [32]. 209
Statistical analysis 210
Differences between missing cases and those that 211
completed the follow-up were analyzed using either 212
parametric or non-parametric tests according to the 213
criteria of normality, for continuous variables, and 214
with the Pearson chi-square test for categorical vari- 215
ables. 216
Longitudinal data were analyzed by means of 217
generalized linear models (GLM), because some 218
dependent variables were not normally distributed 219
[33–34]. This approach enabled us to examine the 220
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Fig. 1. Flowchart showing changes in the sample’s characteristics
over the 24-month period.
general effects of the independent variables (time,221
severity, anosognosia status), and the interaction222
between them (Time × Severity × Anosognosia), as223
well as the simple effects of differences between the224
groups. The dependent variables for each model were225
the number of care hours (total, instrumental and226
basic ADL) and the cost of care (hours and resources).227
For hypothesis contrasts, the level of statistical228
significance was set at 0.05. All data processing229
and analysis was performed using IBM SPSS Statis-230
tics for Windows, version 20.0 (Armonk, NY: IBM231
Corp.).232
RESULTS233
The baseline sample comprised 221 patients and234
their respective caregivers, of whom 75.1% com-235
pleted the follow-up assessment at 12 months and236
57.5% the assessment at 24 months. At baseline, only237
four families of those initially invited declined to238
participate. Lost cases (n = 94) were more impaired239
at baseline than were patients who completed the240
follow-up (n = 127); specifically, they had greater241
cognitive impairment (MMSE = 17.2 versus 19.1;242
p = 0.014), poorer functional ability (DAD = 54.7243
versus 60.6; p < 0.001), a greater degree of anosog-244
nosia (AQ-D = 38.9 versus 30.2; p = 0.001), and more245
neuropsychiatric symptoms (NPI = 31.2 versus 20.9;246
p < 0.001). Fig. 1 shows the drop off reasons over the247
24-month period.248
Sociodemographic and clinical data249
The sociodemographic and clinical characteristics250
of the study participants at each visit are shown in251
Table 2. The mean age of caregivers at baseline was 252
63.8 (SD = 13.0), 151 (68.3%) were women, and 56 253
(25.3%) had fewer than five years of formal edu- 254
cation. Spouses accounted for 54.7% of informal 255
caregivers (54.8% women), while 40.7% were sons 256
or daughters of the patient (77.0% women). 257
Needs and use of services 258
The caregivers provided, on average, 5 h/day of 259
informal care (SD = 2.4; range = 0–12), distributed 260
across BADL (1.3 h/day; SD = 1.4; range = 0–6) and 261
IADL (3.6 h/day; SD = 1.4; range = 0–6). Time of 262
care was related to the dementia severity (GDS). 263
Thus, the time requested by GDS4 patients was 264
2.6 h/day (SD = 1.7), while for GDS6 patients it was 265
7.0 h/day (SD = 1.8) (F = 274.8; df = 2; p < 0.001). 266
The time of care showed a moderate correlation with 267
BPDS (rho = 0.405; p < 0.001) but when including the 268
NPI score as an independent variable in the GLM, the 269
relation with cost over 24 months was not significant 270
(F = 1.449; df = 487; p = 0.229). 271
The resources used by the patients and their care- 272
givers are described in Table 3. At the 24-month 273
follow-up, 74.5% of cases used, at least once, the 274
available health and social services. The proportion of 275
patients using these resources did not change during 276
the two-year study period: 68.8% at baseline, 74.7% 277
at 12 months, and 66.1% at 24 months (χ2 = 4.6; 278
df = 2; p = 0.101). Across the 24 months of follow-up 279
4.7% of patients were institutionalized. 280
Impact of anosognosia on the care received 281
by patients 282
Anosognosia was observed in 54.3% of the patients 283
at baseline. Over the follow-up period, 27.2% of 284
the cases (n = 140) remained asymptomatic, 22.2% 285
(n = 114) presented with anosognosia at either 12 or 286
24 months (patients without anosognosia at base- 287
line who developed it during the follow up), and 288
anosognosia persisted in 50.6% (n = 260) of the cases 289
(anosognosia present at baseline and during the fol- 290
low up). A request for help from the relatives and/or 291
the use of services was registered in 82.9% of the 292
cases with anosognosia versus 61.8% of those with- 293
out anosognosia (χ2 = 28.9; df = 2; p < 0.001). 294
From baseline onwards, patients with anosognosia 295
required more hours of care than did their asymp- 296
tomatic counterparts (Wald = 37.1; df = 2; p < 0.001). 297
During the follow-up period, asymptomatic cases 298
were also less likely to use health and social 299
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Table 2
Clinical and sociodemographic data of patients
Baseline1 12 months2 24 months3 Differences
(n = 221) (n = 166) (n = 127) p
Age 77.8 (0.4) 78.6 (0.5) 79.0 (0.6) 0.276∗
Women 140 (63.3) 104 (62.7) 82 (64.6) 0.944∗∗
Education 0.864∗∗
<Primary school 140 (63.3) 108 (65.1) 84 (66.1)
≥Primary school 81 (36.7) 58 (34.9) 43 (33.9)
GDS, n (%) <0.001∗∗
4 97 (43.9) 38 (22.9) 12 (9.4)
5 78 (35.3) 67 (40.4) 40 (31.5)
6 46 (20.8) 61 (36.7) 75 (59.1)
MMSE, mean (SD) 18.3 (0.4) 16.3 (0.4)a 15.2 (0.5)b <0.001∗
DAD, mean (SD) 58.1 (0.7) 54.0 (0.8)a 50.0 (0.9)b,c <0.001∗
IADL 30.2 (0.4) 28.1 (0.4)a 26.3 (0.5)b,c <0.001∗
BADL 27.9 (0.3) 25.8 (0.4)a 23.6 (0.5)b,c <0.001∗
NPI, mean (SD) 25.3 (1.2) 24.4 (1.4) 28.6 (1.6) <0.001∗
AQ-D (>32), n (%) 120 (54.3) 106 (63.9) 84 (66.1) 0.049∗∗
Factor 1 28.8 (1.0) 29.4 (1.3) 31.6 (1.7) 0.361∗
Factor 2 5.1 (0.3) 4.9 (0.4) 4.7 (0.5) 0.696∗
Difference 33.9 (1.2) 36.4 (1.4) 37.9 (1.6) 0.135∗
∗∗Pearson χ2 test for categorical variables. ∗Generalized linear model, Wald χ2. Means, estimated marginal. SE,
standard error. Significant with Bonferroni post hoc contrasts: a1–2, b1–3, c2–3. Fixed effects, time. Covariables,
else: GDS, Global Deterioration Scale. MMSE, Mini Mental State Examination. DAD, Disability Assessment
for Dementia. IADL, instrumental activities of daily living. BADL, basic activities of daily living, NPI, Neu-
ropsychiatric Inventory. AQ-D, Anosognosia Questionnaire-Dementia (>32: Anosognosia); Factor 1, cognitive
and functional. Factor 2, behavioral.
Table 3
Frequency of use of different support services according to the presence or absence of anosognosia, stratified by assessment point
Baseline 12 months 24 months
n (%) No anosognosia Anosognosia p No anosognosia Anosognosia p No anosognosia Anosognosia p
Memory-Training programs 15 (14.9) 10 (8.3) 0.128 14 (23.3) 16 (15.1) 0.185 6 (14.0) 12 (14.3) 0.959
Day center 0.029 0.045 0.616
No 83 (82.2) 81 (67.5) 52 (86.7) 75 (70.8) 33 (76.7) 61 (72.6)
Weekly 10 (9.9) 16 (13.3) 0 (0.0) 4 (3.8) 0 (0.0) 0 (0.0)
Daily 8 (7.9) 23 (19.2) 8 (13.3) 27 (25.5) 10 (23.3) 23 (27.4)
Home care service 0.320 0.697 0.043
No 74 (73.3) 80 (66.7) 45 (75.0) 71 (67.0) 33 (76.7) 54 (64.3)
Occasionally 6 (5.9) 5 (4.2) 4 (6.7) 7 (6.6) 0 (0.0) 10 (11.9)
Weekly 13 (12.9) 16 (13.3) 6 (10) 16 (15.1) 7 (16.3) 8 (9.5)
Daily 8 (7.9) 19 (15.8) 5 (8.3) 12 (11.3) 3 (7.0) 12 (14.3)
Residential care 1 (1.0) 4 (3.3) 0.243 0 (0.0) 5 (4.7) 0.088 3 (7.0) 11 (13.1) 0.297
Alzheimer’s Association 25 (24.8) 45 (37.5) 0.042 25 (41.7) 45 (42.5) 0.922 19 (44.2) 32 (38.1) 0.508
Use of resources 59 (58.4) 93 (77.5) 0.002 35 (58.3) 89 (84.0) <0.001 32 (74.4) 75 (89.3) 0.030
GDS 4 36 (50.0) 19 (76.0) 0.024 14 (51.9) 10 (90.9) 0.024 5 (45.5) 1 (100) 0.296
GDS 5 18 (78.3) 39 (70.9) 0.504 17 (70.8) 30 (69.8) 0.927 12 (85.7) 19 (73.1) 0.361
GDS 6 5 (83.5) 35 (87.5) 0.777 4 (44.4) 49 (94.2) <0.001 15 (83.3) 55 (96.5) 0.051
Pearson χ2 test for categorical variables. GDS, Global Deterioration Scale. Occasionally = 1 day/week. Weekly = 2–4 days/week. Daily = 5–7
days/week. Alzheimer’s Association, affiliation to the local Alzheimer’s Association or similar.
services than patients with incident or persis-300
tent anosognosia (χ2 = 9.3; df = 2; p = 0.009). The301
mean time dedicated by caregivers to help with302
the patient’s BADL was 1.1 h/day for asymp-303
tomatic cases (SE = 0.1), 1.2 h/day for the incident304
group (SE = 0.1), and 1.4 h/day (SE = 0.1) for per-305
sistent cases; the corresponding figures for IADL306
were 3.2 h/day (SE = 0.1), 3.7 h/day (SE = 0.1), and307
3.9 h/day (SE = 0.1), respectively. The presence of 308
anosognosia increased the use of health and social 309
services, including institutionalization (χ2 = 5.5; 310
df = 2; p = 0.018). Overall, resources were used by 311
50.5% of the asymptomatic cases versus 66.8% 312
of patients with anosognosia (χ2 = 13.6; df = 2; 313
p < 0.001). Alongside anosognosia, the severity of 314
dementia was the other main factor associated with 315
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the use of resources: one or more resources were used316
by 53.7% of patients at GDS stage 4, by 56.8% of317
those at GDS 5, and by 69.2% of those at GDS 6318
(χ2 = 9.6; df = 2; p = 0.008) (Table 3).319
The presence of anosognosia was associated with320
an increase in the time dedicated to the informal care321
of the patients, regardless of the dementia severity322
(Wald = 9.0; df = 2; p = 0.011). Figure 2 shows the323
number of hours dedicated per day to provide help324
with BADL and IADL, according to the severity of325
dementia and stratified by the patient’s anosognosia326
status.327
Attribution of costs328
Based on the attribution of cost per hour of care, the329
cost of informal care was 851.9D /month (SD = 546.2;330
range = 0–2,091.9D ) for BADL and 544.7D /month331
(SD = 349.2; range = 0–1337.6D ) for IADL. The332
cost of all support services was 490.4D /month333
(SD = 413.1; range = 25–2,212.38D ); the cost of334
home care services was 259.3D /month (SD = 115.4;335
range = 77.5–378.7D ), while it was 552.1D /month336
(SD = 119.0; range = 336.7–617.3D ) for day cen-337
ter attendance. The total cost across the 24-month338
follow-up period was 1,787D /month (SD = 972.4),339
with the cost of informal care (caregiver hours)340
accounting for 83.4% of the total. The cost of sup-341
port services was significantly higher at 24 months342
(F = 3.6; df = 2; p = 0.026).343
In the generalized linear model the total cost of344
care (support services plus caregiver hours) did not345
differ significantly between baseline, 12 months, and346
24 months (Wald = 0.374; df = 2; p = 0.829), and nei-347
ther was there an interaction effect (Time × Severity348
of Dementia × Anosognosia) on this total cost349
(Wald = 179.7; df = 15; p = 0.279). Therefore, the350
analysis of total cost was stratified only according351
to anosognosia status and to the severity of dementia352
(Wald = 11.1; df = 4; p = 0.026). However, a summary353
table showing the variable Time has been included354
as Supplementary Material (Supplementary Table 1).355
Table 4 shows that the lowest cost corresponded to356
asymptomatic cases (no anosognosia) at GDS stage357
4 (834.0D /month), whereas the highest cost corre-358
sponded to cases with incident anosognosia and at359
GDS 6 (2,424.8D /month).360
DISCUSSION361
The main purpose of this work was to describe362
the effect of anosognosia in the cost of care, using363
the daily hours of care and the use of resources as 364
cost-indicators. 365
The informal care provided by relatives is 366
fundamental to AD patients’ attention. Principal char- 367
acteristics of AD, such as functional dependence 368
and neuropsychiatric symptoms are the main factors 369
related with an increase of the time of care. How- 370
ever, both the perceptions of caregiving stress and the 371
positive aspects of caregiving are appraised through 372
a cultural/ethnic lens [35], and whereas Caucasians 373
generally place earlier the loved ones in care facilities 374
[36], African Americans and Latinos tend to delay 375
institutionalization [37]. Informal care is usually pro- 376
vided by close relatives, especially if one of these 377
is a woman. In agreement with previous research, 378
our results show that external support services still 379
account for a relatively small proportion of the over- 380
all care that is provided (around 15% of the total 381
cost). 382
However, although traditional roles and relation- 383
ships persist within the provision of informal care in 384
Spain, research suggests that caregivers are beginning 385
to ask for different kinds of help from government 386
agencies [1]. Whereas twenty years ago caregivers 387
were most likely to request financial assistance in 388
the form of a monthly caregiver allowance, the main 389
demand nowadays is for home care services and 390
greater training. These home care services would 391
include the use of day care centers and the access to 392
other kind of formal support, such as tele-care [38]. 393
Several studies have reported specific data about 394
the cost of formal and informal care to patients 395
with dementia [39–41]. The factors that influence 396
the cost of care can be classified in two groups: 397
dementia-directly related factors and factors related 398
to caregiver’s burden. The first group encloses func- 399
tional disability, anosognosia, and neuropsychiatric 400
symptoms, among others [42]. In our analyses neu- 401
ropsychiatric symptoms were not significant, which 402
may be due to the fact that dementia severity 403
is influenced-by the presence of neuropsychiatric 404
symptoms. In another study, the NPI scores were 405
barely related with an increment of the caregiving 406
costs, and it was the dependence scale that largely 407
explained the variance of the caregiving costs [43]. 408
The second group is related with the caregiver burden 409
perception. We previously reported an increase of the 410
burden perception associated with anosognosia [20], 411
and there is evidence that greater burden is related to 412
a greater use of resources [44]. We did not include 413
the burden in our study due to its strong relationship 414
with anosognosia. 415
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Fig. 2. Number of hours dedicated per day to helping with basic and instrumental ADL, according to the severity of dementia and stratified
by the patient’s anosognosia status.
Table 4
Total combined monthly cost of informal care by family caregivers and external support services, stratified by severity of dementia and
anosognosia status
TOTAL COST GDS 4 GDS 5 GDS 6 Simple Effects
n Mean (SE) n Mean (SE) n Mean (SE) χ2; (df); p
Total cost 147 1189.2 (72.4) 185 1815.0 (64.4)a 182 2243.9 (64.9)b,c 118.1; (2); <0.001
Anosognosia status
1. No anosognosia 74 834.0 (101.2) 38 1,704.4 (138.1)a 28 2,099.5 (162.4)a,b 52.9; (2); <0.001
2. Incidence 41 1,324.8 (137.9)d 47 1,927.5 (124.1)a 26 2,424.8 (169.7)a,b 24.9; (2); <0.001
3. Persistence 32 1,715.1 (155.8)e 100 1,790.6 (87.7) 128 2,248.1 (75.2)b,c 19.2; (2); <0.001
Simple Effects: χ2; (df); p 25.7; (2);<0.001 1.5; (2); 0.472 1.9; (2); 0.373
Model χ2 (df) p: = 147.9 (8) < 0.001; Time = 0.923 (2) 0.630; Anosognosia groups = 15.2 (2) 0.001; GDS = 63.7 (2) < 0.001;
GDS∗Anosognosia groups = 13.1 (4) 0.011; Generalized linear model, Wald χ2, for GDS, anosognosia groups and interaction; Simple
effects, Wald χ2, for differences between groups; Means, estimated marginal; SE, standard error; Significant with Bonferroni post hoc
contrasts: aGDS 4–5, bGDS 4–6, cGDS 5–6; d1–2; e1–3; f 2–3.
In most cost analyses, the severity of dementia416
emerges as the main factor associated with increased417
costs of informal care for people with AD [45]. As418
expected, in our study, greater severity increased both419
the number of hours of informal care required and420
the use of health and social support services. How-421
ever, the inclusion of the presence of anosognosia as422
a variable in our analysis revealed important differ-423
ences both in care hours and the use of resources. The424
total cost of care increased in an almost linear manner425
from mild cases of dementia without anosognosia, to 426
cases with incident or persistent anosognosia and at 427
GDS stage 6. 428
In cases without anosognosia and at GDS stage 4, 429
the monthly cost of care was over 830D , which is 1.29 430
times the minimum wage in Spain (648.60D /month) 431
[46]; it should be noted, however, that part of this 432
cost is borne by the government through dependency 433
allowances [47]: in the present study, this was the 434
case for 21.7% of patients with mild dementia and 435
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84.8% of the most severe (GDS 6) cases. It should436
also be noted that while the figures obtained here437
are considerably high, the Catalan National Health438
System and Social Services subsidize part of the439
cost, which increases equitability. As for compar-440
isons with previous research, the mean total cost of441
1,787D /month is in line with the figures reported by442
other studies in Spain [40, 48], similar to the figures443
in Ireland [49], and slightly less than the cost docu-444
mented in Germany, the UK, and France [50]. The445
cost of care increases with the severity of demen-446
tia, and most studies coincide in terms of the support447
services requested by caregivers and the factors that448
lead to greater care needs (functional disability and449
BPSD) [51]. The present study adds to this picture by450
showing that the presence of anosognosia is another451
factor that increases the cost of care over 300D /month452
on average.453
Interestingly, we did not find an inverse relation-454
ship between the number of hours of informal care455
provided and the use of support services, which sug-456
gests that the availability of such services improves457
the quality of care provided, and the quality of life458
of patients and caregivers, rather than reducing the459
number of hours of informal care per se.460
An increase in the amount of time spent by infor-461
mal caregivers directly correlates with an increase in462
their perceived burden [52–54]. In a previous study463
we observed that the cost of informal care increased464
in line with the patient’s physical disability and cog-465
nitive impairment, as well as if the relative was the466
sole caregiver, with the cost of informal care, explain-467
ing 6.7% of the total variance in the perceived burden468
of caregivers [40]. We also reported that the presence469
of anosognosia was a determining factor in terms of470
greater caregivers’ perceived burden [20, 55]. The471
results of the present study highlight the need for472
more specific help to be offered to caregivers in rela-473
tion to the impact that anosognosia in the patient474
can have, and the implications it has for home-based475
care [15, 53]. Future research may include a per-476
ceived economic burden measure, as well as some477
data regarding the “opportunity costs” related with a478
possible loss of opportunities due to the time spent479
as a caregiver. In the context of resource manage-480
ment, maintaining or improving the quality of life481
of patients and caregivers is one of the main ways482
in which the costs of health and social care can be483
reduced [56].484
Previously, many studies examined the indirect485
cost based on caregivers’ self-reported number of486
hours with no external validation. Also, our study487
did not include the “opportunity costs” to care- 488
givers and only included the “market price” for each 489
hour reported. These limitations have influenced both 490
the number of hours reported and the associated 491
attributed cost. However, both figures are similar to 492
those documented by other studies in Spain and inter- 493
nationally [24, 48–49]. Even though the resources and 494
their access are not equal everywhere, we decided 495
to describe their use in a specific work-class neigh- 496
borhood of Barcelona where the possibilities and the 497
accessibility were as similar as possible. 498
CONCLUSIONS 499
Anosognosia is a frequent symptom in AD patients 500
and it has a major impact to caregivers, increasing 501
their time of care and the use of support services. 502
The presence of anosognosia implies, therefore, an 503
increase of informal costs. 504
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